Browse > Article
http://dx.doi.org/10.5483/BMBRep.2019.52.7.104

The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation  

Kim, Inyoung (Department of Pharmacology, Chonnam National University Medical School)
Kim, Jung Ha (Department of Pharmacology, Chonnam National University Medical School)
Kim, Kabsun (Department of Pharmacology, Chonnam National University Medical School)
Seong, Semun (Department of Pharmacology, Chonnam National University Medical School)
Kim, Nacksung (Department of Pharmacology, Chonnam National University Medical School)
Publication Information
BMB Reports / v.52, no.7, 2019 , pp. 469-474 More about this Journal
Abstract
Kruppel-like factor 2 (KLF2) has been implicated in the regulation of cell proliferation, differentiation, and survival in a variety of cells. Recently, it has been reported that KLF2 regulates the p65-mediated transactivation of $NF-{\kappa}B$. Although the $NF-{\kappa}B$ pathway plays an important role in the differentiation of osteoclasts and osteoblasts, the role of KLF2 in these bone cells has not yet been fully elucidated. In this study, we demonstrated that KLF2 regulates osteoclast and osteoblast differentiation. The overexpression of KLF2 in osteoclast precursor cells inhibited osteoclast differentiation by downregulating c-Fos, NFATc1, and TRAP expression, while KLF2 overexpression in osteoblasts enhanced osteoblast differentiation and function by upregulating Runx2, ALP, and BSP expression. Conversely, the downregulation of KLF2 with KLF2-specific siRNA increased osteoclast differentiation and inhibited osteoblast differentiation. Moreover, the overexpression of interferon regulatory protein 2-binding protein 2 (IRF2BP2), a regulator of KLF2, suppressed osteoclast differentiation and enhanced osteoblast differentiation and function. These effects were reversed by downregulating KLF2. Collectively, our data provide new insights and evidence to suggest that the IRF2BP2/KLF2 axis mediates osteoclast and osteoblast differentiation, thereby affecting bone homeostasis.
Keywords
IRF2BP2; KLF2; $NF-{\kappa}B$; Osteoblast; Osteoclast;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Leibbrandt A and Penninger JM (2008) RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci 1143, 123-150   DOI
2 Kim JH and Kim N (2016) Signaling Pathways in Osteoclast Differentiation. Chonnam Med J 52, 12-17   DOI
3 Takayanagi H, Kim S, Koga T et al (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3, 889-901   DOI
4 Katagiri T and Takahashi N (2002) Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8, 147-159   DOI
5 Matsubara T, Kida K, Yamaguchi A et al (2008) BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283, 29119-29125   DOI
6 Schroeder TM, Jensen ED and Westendorf JJ (2005) Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 75, 213-225   DOI
7 Boyce BF, Yao Z and Xing L (2010) Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci 1192, 367-375   DOI
8 Kim I, Kim JH, Kim K, Seong S and Kim N (2017) Tusc2/Fus1 regulates osteoclast differentiation through NF-kappaB and NFATc1. BMB Rep 50, 454-459   DOI
9 Bak SU, Kim S, Hwang HJ et al (2017) Heme oxygenase-1 (HO-1)/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-kappaB activation. BMB Rep 50, 103-108   DOI
10 Yamashita T, Yao Z, Li F et al (2007) NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem 282, 18245-18253   DOI
11 Nayak L, Goduni L, Takami Y et al (2013) Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation. Am J Pathol 182, 1696-1704   DOI
12 Yamazaki M, Fukushima H, Shin M et al (2009) Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem 284, 35987-35995   DOI
13 Yao Z, Li Y, Yin X, Dong Y, Xing L and Boyce BF (2014) NF-kappaB RelB negatively regulates osteoblast differentiation and bone formation. J Bone Miner Res 29, 866-877   DOI
14 Lee J, Youn BU, Kim K et al (2015) Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation. J Bone Miner Res 30, 1597-1607   DOI
15 Childs KS and Goodbourn S (2003) Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. Nucleic Acids Res 31, 3016-3026   DOI
16 Dang DT, Pevsner J and Yang VW (2000) The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol 32, 1103-1121   DOI
17 Das H, Kumar A, Lin Z et al (2006) Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc Natl Acad Sci U S A 103, 6653-6658   DOI
18 Das M, Lu J, Joseph M et al (2012) Kruppel-like factor 2 (KLF2) regulates monocyte differentiation and functions in mBSA and IL-1beta-induced arthritis. Curr Mol Med 12, 113-125   DOI
19 Carneiro FR, Ramalho-Oliveira R, Mognol GP and Viola JP (2011) Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity. Mol Cell Biol 31, 2889-2901   DOI
20 Teng AC, Kuraitis D, Deeke SA et al (2010) IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression. FASEB J 24, 4825-4834   DOI
21 Cao Z, Sun X, Icli B, Wara AK and Feinberg MW (2010) Role of Kruppel-like factors in leukocyte development, function, and disease. Blood 116, 4404-4414   DOI
22 Chen HH, Keyhanian K, Zhou X et al (2015) IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis. Circ Res 117, 671-683   DOI
23 Jha P and Das H (2017) KLF2 in Regulation of NF-kappaB-Mediated Immune Cell Function and Inflammation. Int J Mol Sci 18, 2383-2420   DOI
24 SenBanerjee S, Lin Z, Atkins GB et al (2004) KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199, 1305-1315   DOI
25 Boyce BF, Xiu Y, Li J, Xing L and Yao Z (2015) NF-kappaB-Mediated Regulation of Osteoclastogenesis. Endocrinol Metab (Seoul) 30, 35-44   DOI
26 Chang J, Wang Z, Tang E et al (2009) Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 15, 682-689   DOI
27 Zhang H and Reilly MP (2015) IRF2BP2: A New Player at the Crossroads of Inflammation and Lipid Metabolism. Circ Res 117, 656-658   DOI
28 Zhou B, Cron RQ, Wu B et al (2002) Regulation of the murine Nfatc1 gene by NFATc2. J Biol Chem 277, 10704-10711   DOI
29 Ikeda F, Nishimura R, Matsubara T et al (2004) Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest 114, 475-484   DOI